Actelion (Actelion) Dividends per Share : $1.55 (TTM As of Mar. 2017)

View and export this data going back to . Start your Free Trial

What is Actelion Dividends per Share?

Actelion's dividends per share for the three months ended in Mar. 2017 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2017 was $1.55. Its Dividend Payout Ratio for the three months ended in Mar. 2017 was 0.00. As of today, Actelion's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

Actelion Dividends per Share Historical Data

The historical data trend for Actelion's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actelion Dividends per Share Chart

Actelion Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dividends per Share

Get a 7-Day Free Trial

0.87

1.12

1.23

1.31

1.47

Actelion Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Dividends per Share	Get a 7-Day Free Trial															-	1.55	-	-	-

Competitive Comparison of Actelion's Dividends per Share

For the Biotechnology subindustry, Actelion's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Actelion's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actelion's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Actelion's Dividend Yield % falls into.

Actelion Dividends per Share Calculation

Dividends paid to per common share.

Actelion (OTCPK:ALIOF) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Actelion's Dividend Payout Ratio for the quarter that ended in Mar. 2017 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2017 )	/	EPS without NRI (Q: Mar. 2017 )
	=	0	/	1.857
	=	0.00

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Actelion Dividends per Share Related Terms

Thank you for viewing the detailed overview of Actelion's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Actelion (Actelion) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actelion Ltd (OTCPK:ALIOF) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.actelion.com

Actelion is a Swiss biopharmaceutical firm with several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods of administration. Zavesca is a second-line option for Gaucher disease, and Valchlor treats a rare form of blood cancer. Actelion has created a global commercial infrastructure for its approved orphan drugs and has supplemented its internal pipeline through in-licensing and acquisitions.

Actelion (Actelion) Headlines

From GuruFocus

Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary

By Holly LaFon Holly LaFon • 02-14-2017

Actelion Still On Growth Track

By reports.droy reports.droy • 02-18-2015

Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary

By Holly LaFon Holly LaFon • 01-24-2017

Jean Hynes Reduces Stake in Actelion

By Kyle Ferguson Kyle Ferguson • 08-03-2016